Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

Overexpression of TAR-containing sequences (TAR decoys) was used to render cells resistant to HIV replication. A chimeric tRNA(meti)-TAR transcription unit contained in a double copy murine retroviral vector was used to express high levels of HIV-1 TAR-containing transcripts in CEM SS cells. Replication of HIV-1 was inhibited over 99% in cells expressing chimeric tRNA-TAR transcripts, but an amphotropic murine retrovirus replicated normally in these cells. Expression of TAR sequences in CEM SS cells had no adverse effects on cell viability, indicating that essential cellular factors are not being sequestered in these cells. TAR decoy RNA-mediated HIV inhibition may also be effective against natural HIV isolates in spite of their hypervariable nature, as suggested by the fact that replication of SIVmac was also inhibited in cells expressing HIV-1 TAR decoys.

[1]  H. Weintraub,et al.  Anti-sense RNA as a molecular tool for ] genetic analysis , 1985 .

[2]  P. Sharp,et al.  Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Emerman,et al.  Genome organization and transactivation of the human immunodeficiency virus type 2 , 1987, Nature.

[4]  K. Jones.  HIV trans-activation and transcription control mechanisms. , 1989, The New biologist.

[5]  S. Orkin,et al.  Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Romeo,et al.  Transcription and precursor processing of normal and mutant human tRNAiMet genes in a homologous cell-free system. , 1982, The Journal of biological chemistry.

[7]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[8]  K. Steimer,et al.  Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). , 1985, Science.

[9]  S. Le,et al.  Functional analysis of the Tat trans activator of human immunodeficiency virus type 2 , 1989, Journal of virology.

[10]  B. Cullen,et al.  Regulatory pathways governing HIV-1 replication , 1989, Cell.

[11]  M. Zasloff,et al.  Comparative analysis of human chromosomal segments bearing nonallelic dispersed tRNAi met genes , 1981, Cell.

[12]  S. McKnight,et al.  Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus , 1988, Nature.

[13]  T. Lee,et al.  Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication , 1990, Molecular and cellular biology.

[14]  J. Mol,et al.  Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. , 1988, BioTechniques.

[15]  M. Malim,et al.  Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function , 1989, Cell.

[16]  M. Cotten,et al.  Ribozyme mediated destruction of RNA in vivo. , 1989, The EMBO journal.

[17]  R. Cortese,et al.  Order and intracellular location of the events involved in the maturation of a spliced tRNA , 1980, Nature.

[18]  D. Baltimore.  Intracellular immunization , 1988, Nature.

[19]  B. Haynes,et al.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. , 1984, Science.

[20]  S. Goff,et al.  Construction and use of a safe and efficient amphotropic packaging cell line. , 1988, Virology.

[21]  M. Inouye,et al.  The role of antisense RNA in gene regulation. , 1986, Annual review of biochemistry.

[22]  D. Williams,et al.  Restriction of expression of an integrated recombinant retrovirus in primary but not immortalized murine hematopoietic stem cells. , 1988, Blood.

[23]  M. Zasloff,et al.  tRNA nuclear transport: Defining the critical regions of human tRNAi met by point mutagenesis , 1985, Cell.

[24]  Michael R. Green,et al.  Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein , 1990, Nature.

[25]  B. Sullenger,et al.  Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Armentano,et al.  Effect of internal viral sequences on the utility of retroviral vectors , 1987, Journal of virology.

[27]  P. Sharp,et al.  HIV TAR: An RNA enhancer? , 1989, Cell.

[28]  K. Jeang,et al.  Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Baltimore,et al.  HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus , 1989, Cell.

[30]  D. Baltimore,et al.  The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. , 1987, The EMBO journal.

[31]  G. Shaw,et al.  Extensive variation of human immunodeficiency virus type-1 in vivo , 1988, Nature.

[32]  W. Gerlach,et al.  Simple RNA enzymes with new and highly specific endoribonuclease activities , 1988, Nature.

[33]  P. Nara,et al.  Quantitative infectivity assay for HIV-1 and -2 , 1988, Nature.

[34]  J. Levy,et al.  Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. , 1985, Virology.

[35]  R. Gaynor,et al.  Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Baltimore,et al.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase , 1981, Journal of virology.

[37]  R. Jaenisch,et al.  De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[39]  J. Rossi,et al.  Ribozymes as potential anti-HIV-1 therapeutic agents. , 1990, Science.

[40]  P. Romeo,et al.  Generation of long read-through transcripts in vivo and in vitro by deletion of 3' termination and processing sequences in the human tRNAimet gene. , 1984, Nucleic acids research.

[41]  R. Desrosiers,et al.  Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. , 1985, Science.

[42]  B. Cullen,et al.  Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. , 1987, Proceedings of the National Academy of Sciences of the United States of America.